Liquorice and its health implications

被引:73
作者
Olukoga, A
Donaldson, D
机构
[1] Crawley Hosp, Crawley, W Sussex, England
[2] E Surrey Hosp, Surrey, England
来源
JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH | 2000年 / 120卷 / 02期
关键词
commercial use; glycyrrhizinic acid (GZA); liquorice; medicinal value; metabolic consequences;
D O I
10.1177/146642400012000203
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article presents an overview of the health implications of liquorice, Liquorice has beneficial applications in the medicinal and the confectionery sectors; the substance, therefore, is both widely available and commercially attractive. However, the ingestion of liquorice, and/or its active metabolites, can sometimes produce an acquired form of apparent mineralocorticoid excess (AME) syndrome, expressed as sodium retention, potassium loss and suppression of the renin-angiotensin-aldosterone system, in addition to clinical consequences such as raised blood pressure and oedema. Moreover, these metabolic changes, the mechanisms underlying which are highlighted in the accompanying text, are associated with a number of additional clinical symptoms. Considering the easy availability of liquorice itself and also of other products containing its active metabolites, it is quite possible that the health burden of liquorice-induced morbidity could be substantial. Healthcare practitioners need to be fully aware of the risks in view of a large number of reports in the literature concerning its toxicity.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 57 条
  • [41] Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man
    Palermo, M
    Shackleton, CHL
    Mantero, F
    Stewart, PM
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (05) : 605 - 611
  • [42] EFFECT OF CARBENOXOLONE ON PROSTAGLANDIN SYNTHESIS AND DEGRADATION
    PESKAR, BM
    HOLLAND, A
    PESKAR, BA
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (02) : 146 - 148
  • [43] CARBENOXOLONE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN PEPTIC-ULCER DISEASE
    PINDER, RM
    BROGDEN, RN
    SAWYER, PR
    SPEIGHT, TM
    SPENCER, R
    AVERY, GS
    [J]. DRUGS, 1976, 11 (04) : 245 - 307
  • [44] REEVERS FE, 1948, NED TIJDSCHR GENEES, V92, P2968
  • [45] REYNOLDS JEF, 1993, MARTINDALE EXTRA PHA, P888
  • [46] CHEWING GUM AND HYPOKALEMIA
    ROSSEEL, M
    SCHOORS, D
    [J]. LANCET, 1993, 341 (8838) : 175 - 175
  • [47] SAITO T, 1994, JAP J NEPH, V36, P1308
  • [48] Therapeutic basis of glycyrrhizin on chronic hepatitis B
    Sato, H
    Goto, W
    Yamamura, J
    Kurokawa, M
    Kageyama, S
    Takahara, T
    Watanabe, A
    Shiraki, K
    [J]. ANTIVIRAL RESEARCH, 1996, 30 (2-3) : 171 - 177
  • [49] 11 beta-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action?
    Seckl, JR
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1997, 18 (01) : 49 - 99
  • [50] APPARENT MINERALOCORTICOID EXCESS SYNDROMES
    SHIMOJO, M
    STEWART, PM
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (07) : 518 - 532